Publications by authors named "Clotilde Descarpentries"

Claim this Profile
M
MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation.
Célia Guérin, Audrey Vinchent, Marie Fernandes, Isabelle Damour, Agathe Laratte, Clotilde Descarpentries

Mol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation.
Célia Guérin, Audrey Vinchent, Marie Fernandes, Isabelle Damour, Agathe Laratte, Clotilde Descarpentries

bioRxiv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capmatinib efficacy for METex14 non-small cell lung cancer patients: Results of the IFCT-2104 CAPMATU study.
Marion Ferreira, Aurélie Swalduz, Laurent Greillier, Pauline du Rusquec, Hubert Curcio, Clotilde Descarpentries

Lung Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of 164 patients with NRAS mutated non-small cell lung cancer (NSCLC).
Agathe Dehem, Julien Mazieres, Ali Chour, Florian Guisier, Marion Ferreira, Clotilde Descarpentries

Lung Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)-dependent oncogenic driver in vitro and in humanised HGF knock-in mice.
Marie Fernandes, Brynna Hoggard, Philippe Jamme, Sonia Paget, Marie-José Truong, Clotilde Descarpentries

Mol Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transforming properties of MET receptor exon 14 skipping can be recapitulated by loss of the CBL ubiquitin ligase binding site.
Marie Fernandes, Sonia Paget, Zoulika Kherrouche, Marie-José Truong, Audrey Vinchent, Clotilde Descarpentries

FEBS Lett· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical response under MEK inhibitor alone in metastatic melanoma with a novel fusion involving the RAF1 gene.
Marie Boileau, Clotilde Descarpentries, Guillaume Delzenne, Victorine Trentesaux, Anna Greliak

Melanoma Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Capmatinib in a MET Fusion-positive Cholangiocarcinoma.
Anthony Turpin, Clotilde Descarpentries, Valérie Grégoire, Olivier Farchi, Alexis B Cortot

Oncologist· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to BRAF and MEK Inhibitors in BRAF Thr599dup-Mutated Melanoma.
Marion Oberlé, Philippe Jamme, Sandrine Mansard, Laurent Machet, Alice Hervieu, Clotilde Descarpentries

JCO Precis Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete and prolonged response to anti-PD1 therapy in an ALK rearranged lung adenocarcinoma.
Simon Baldacci, Valérie Grégoire, Enrico Patrucco, Roberto Chiarle, Philippe Jamme, Clotilde Descarpentries

Lung Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations in the PI3K Pathway Drive Resistance to MET Inhibitors in NSCLC Harboring MET Exon 14 Skipping Mutations.
Philippe Jamme, Marie Fernandes, Marie-Christine Copin, Clotilde Descarpentries, Fabienne Escande

J Thorac Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study.
Simon Baldacci, Martin Figeac, Martine Antoine, Clotilde Descarpentries, Zoulika Kherrouche

J Thorac Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial heterogeneity of mutations in colorectal cancers in northern France.
Anthony Turpin, Michael Genin, Mohamed Hebbar, Florent Occelli, Caroline Lanier, Clotilde Descarpentries

Cancer Manag Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of Detection of Mechanisms of Resistance to ALK Inhibitors in ALK-Rearranged NSCLC in Routine Practice.
Philippe Jamme, Clotilde Descarpentries, Radj Gervais, Eric Dansin, Marie Wislez

Clin Lung Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients.
Clotilde Descarpentries, Frédéric Leprêtre, Fabienne Escande, Zoulika Kherrouche, Martin Figeac

J Thorac Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers.
Alexis B Cortot, Zoulika Kherrouche, Clotilde Descarpentries, Marie Wislez, Simon Baldacci

J Natl Cancer Inst· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three Rounds of External Quality Assessment in France to Evaluate the Performance of 28 Platforms for Multiparametric Molecular Testing in Metastatic Colorectal and Non-Small Cell Lung Cancer.
Elisabeth M C Dequeker, Cleo Keppens, Caroline Egele, Sofie Delen, Aude Lamy, Clotilde Descarpentries

J Mol Diagn· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosine kinase inhibitors induce down-regulation of c-Kit by targeting the ATP pocket.
Diane D'allard, Julie Gay, Clotilde Descarpentries, Emilie Frisan, Kevin Adam

PLoS One· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Modification of Diet in Renal Disease formula similar to Cockcroft-Gault formula to assess renal function in elderly hospitalized patients treated with low-molecular-weight heparin?
Isabelle Gouin-Thibault, Eric Pautas, Isabelle Mahé, Clotilde Descarpentries, Valérie Nivet-Antoine

J Gerontol A Biol Sci Med Sci· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pharmacologic treatment of diabetes].
Pascale De Montigny, Carole Clerc, Clotilde Descarpentries

Perspect Infirm· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis